Eli Lilly and Company (LLY)
NYSE · Healthcare
Eli Lilly and Company EBITDA 2020–2025
Eli Lilly and Company annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Eli Lilly and Company ebitda for the quarter ending March 31, 2026 was 11.2 B, a 88.47% increase year-over-year.
- Eli Lilly and Company ebitda for the twelve months ending March 31, 2026 was 40.3 B.
- Eli Lilly and Company annual ebitda for 2025 was 35.1 B, a 80.69% increase from 2024.
- Eli Lilly and Company annual ebitda for 2024 was 19.4 B, a 55.90% increase from 2023.
- Eli Lilly and Company annual ebitda for 2023 was 12.5 B, a 21.82% increase from 2022.
- Eli Lilly and Company annual ebitda for 2022 was 10.2 B.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Eli Lilly and Company EBITDA — FAQ
Eli Lilly and Company (LLY) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LLY's ebitda history?
The chart and table above show Eli Lilly and Company's ebitda by year and by quarter, including the growth rate.